
|Articles|August 1, 2000
Postmenopausal HRT and CHD: clinical implications of recent randomized trial res
Results of the HERS, ERA, and WHI trials suggest a conservative approach to use of HRT in women with evidence of CHD. Dose and duration of therapy may be key to the risk-benefit equation.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Criminalizing prenatal drug use linked to reduced prenatal care
2
Elisabet Stener-Victorin, PhD, highlights 4 unique PCOS subtypes for personalized care
3
Prenatal COVID-19 exposure linked to adverse offspring neurodevelopment
4
AMH levels predict fertility treatment success in cancer patients
5
















